3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
53
Brain Neoplasms
51
Carcinoma, Non-Small-Cell Lung
49
Lung Neoplasms
30
Neoplasm Metastasis
29
Breast Neoplasms
23
Pancreatic Neoplasms
16
Melanoma
15
Carcinoma, Renal Cell
14
Carcinoma, Hepatocellular
13
Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Colorectal Neoplasms
8
Urinary Bladder Neoplasms
7
Small Cell Lung Carcinoma
7
Kidney Neoplasms
5
Liver Neoplasms
4
Glioblastoma
4
Uveal Melanoma
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Prostate Cancer Metastatic
3
NSCLC
3
Meningioma
3
Lymphatic Metastasis
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Transitional Cell
3
Interventions
tremelimumab
4
Ipilimumab
4
lenvatinib
3
durvalumab
3
Nivolumab
3
pembrolizumab
2
balstilimab
2
Pemetrexed
2
Carboplatin
2
Bevacizumab
2
spartalizumab
1
relatlimab
1
poly ICLC
1
osimertinib
1
cemiplimab
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Standard of Care
1
Platinum
1
Peptides
1
Paclitaxel
1
Opdualag
1
Docetaxel
1
Capecitabine
1
Blood Specimen Collection
1
Axitinib
1
Antibodies, Bispecific
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Radiosurgery
×
1 year
×
Clear all
No trials found.